HULC promoted the progression of HCC and inhibited Oxa sensitivity by regulating miR‐383‐5p/VAMP2 axis, elucidating a novel regulatory mechanism for chemosensitivity of Oxa and providing a potential lncRNA‐targeted therapy for HCC. This evidence concerns the gene VAMP2 and hepatocellular carcinoma.